secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0001664710-23-000036
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Keros shareholders elect Gordon, Kariv as directors; ratify Deloitte as auditor
-------------------------------------------------------------------------------

- Carl L. Gordon elected with 11.5M votes for, 13.4M withheld, 1.9M broker non-votes.
- Tomer Kariv elected with 19.2M votes for, 5.7M withheld, 1.9M broker non-votes.
- Ratification of Deloitte & Touche as independent auditor approved: 26,790,800 for, 2,224 against, 1 abstain.
- No broker non-votes on auditor ratification proposal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471023000036/0001664710-23-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471023000036/kros-20230606.htm
  HTML page:      https://secwatch.observer/filing/0001664710-23-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer